Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSBK
2376
DELISTED
First South Bancorp Inc/VA
FSBK
| $464K | ﹤0.01% |
59,500
+5,900
| +11% | +$40.9K |
|
2377
First Bancorp
FNLC
$402M
| $463K | ﹤0.01% |
26,600
-20
| -0.1% | -$346 |
|
2378
Silicon Laboratories
SLAB
$7.3B
| $463K | ﹤0.01% |
10,700
-201,298
| -95% | -$8.24M |
|
|
EGT
2379
DELISTED
Entertainment Gaming Asia Inc.
EGT
| $462K | ﹤0.01% |
93,213
+1,075
| +1% | +$5.58K |
|
|
CBR
2380
DELISTED
CIBER Inc.
CBR
| $460K | ﹤0.01% |
111,000
-47,300
| -30% | -$169K |
|
2381
Cass Information Systems
CASS
$750M
| $458K | ﹤0.01% |
+8,976
| New | +$401K |
|
2382
Iridium Communications
IRDM
$5.26B
| $454K | ﹤0.01% |
+72,649
| New | +$439K |
|
|
IMI
2383
DELISTED
Intermolecular, Inc.
IMI
| $453K | ﹤0.01% |
91,989
+49,889
| +119% | +$282K |
|
2384
Eterna Therapeutics
ERNA
$5.16M
| $451K | ﹤0.01% |
1
| – | – |
|
2385
Rexford Industrial Realty
REXR
$8.11B
| $450K | ﹤0.01% |
+34,100
| New | +$462K |
|
|
HDNG
2386
DELISTED
Hardinge Inc
HDNG
| $449K | ﹤0.01% |
+31,062
| New | +$461K |
|
|
ALSK
2387
DELISTED
Alaska Communications Systems
ALSK
| $448K | ﹤0.01% |
211,100
-650,940
| -76% | -$1.5M |
|
|
PCMI
2388
DELISTED
PCM, Inc
PCMI
| $446K | ﹤0.01% |
43,400
-1,200
| -3% | -$12.1K |
|
|
PDO
2389
DELISTED
PYRAMID OIL CO
PDO
| $446K | ﹤0.01% |
88,400
+6,000
| +7% | +$30.9K |
|
2390
Lexicon Pharmaceuticals
LXRX
$1.04B
| $443K | ﹤0.01% |
+35,192
| New | +$560K |
|
2391
Odyssey Marine Exploration
OMEX
$49.9M
| $443K | ﹤0.01% |
+18,283
| New | +$510K |
|
2392
SemiLEDS
LEDS
$17.6M
| $441K | ﹤0.01% |
47,050
-20,520
| -30% | -$227K |
|
|
IIN
2393
DELISTED
IntriCon Corporation
IIN
| $440K | ﹤0.01% |
114,100
+500
| +0.4% | +$2.04K |
|
|
HH
2394
DELISTED
Hooper Holmes Inc
HH
| $438K | ﹤0.01% |
55,040
-2,953
| -5% | -$24.9K |
|
|
CSG
2395
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $438K | ﹤0.01% |
+57,200
| New | +$487K |
|
|
ATEA
2396
DELISTED
ASTEA INTERNATIONAL INC
ATEA
| $438K | ﹤0.01% |
171,800
-1,200
| -0.7% | -$3.36K |
|
|
WILN
2397
DELISTED
Wi-LAN Inc.
WILN
| $437K | ﹤0.01% |
130,800
-33,700
| -20% | -$115K |
|
|
GPL
2398
DELISTED
Great Panther Mining Limited
GPL
| $435K | ﹤0.01% |
59,650
+8,150
| +16% | +$62.9K |
|
2399
AMCON Distributing
DIT
$66.4M
| $432K | ﹤0.01% |
8,100
+300
| +4% | +$15.9K |
|
|
HXM
2400
DELISTED
DESARROLLADORA HOMES DA DE CV (HOMEX DEV. CORP)
HXM
| $432K | ﹤0.01% |
369,377
-118,723
| -24% | -$169K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.